Pharmacognosy: Current Herbal Medications and Natural Product Chemistry for a PharmD Curriculum focuses on the regulation and practicum of herbal medications in the real world. By introducing natural products as lead compounds for drug design, discovery, and development, the text bridges the gap between traditional herbal medications and current Western medicines. The book covers the unique and rich history of pharmacognosy in pharmacy practice and the critical role it has and continues to play in the evolution of modern Western medicine. Part I contains readings that provide students with an overview of the history of pharmacognosy, as well as the contemporary use of herbal medicine around the globe. In Part II, students learn about dietary supplements, botanical ingredients, herbal bioavailability, pharmacokinetics, and the mechanisms of herb-drug interactions. Part III covers natural products that can be used for pain management, anxiety and insomnia treatment, immune modulation, treating inflammation, infectious diseases, cancer, and more. The final part features case studies to demonstrate the practical applications of pharmacognosy. Featuring contemporary research and information that satisfies Accreditation Council for Pharmacy Education (ACPE) Standards, Pharmacognosy is ideal for courses and programs in pharmacy and medicinal chemistry.

The dean of business historians continues his masterful chronicle of the transforming revolutions of the twentieth century begun in "Inventing the Electronic Century."

Alfred Chandler argues that only with consistent attention to research and development and an emphasis on long-term corporate strategies could firms remain successful over time. He details these processes for nearly every major chemical and pharmaceutical firm, demonstrating why some companies forged ahead while others failed.

By the end of World War II, the chemical and pharmaceutical industries were transformed by the commercializing of new learning, the petrochemical and the antibiotic revolutions. But by the 1970s, chemical science was no longer providing the new learning necessary to commercialize more products, although new directions flourished in the pharmaceutical industries. In the 1980s, major drug companies, including Eli Lilly, Merck, and Schering Plough, commercialized the first biotechnology products, and as the twenty-first century began, the infrastructure of this biotechnology revolution was comparable to that of the second industrial revolution just before World War I and the information revolution of the 1960s. "Shaping the Industrial Century" is a major contribution to our understanding of the most dynamic industries of the modern era.